Valuation: Sandu Pharmaceuticals Limited

Market Cap 295M 3.1M 2.68M 2.5M 2.3M 4.32M 4.39M 29.36M 11.52M 148M 11.63M 11.38M 489M P/E 2024
38x
P/E 2025 30.6x
Enterprise Value 273M 2.87M 2.48M 2.32M 2.13M 4M 4.06M 27.2M 10.67M 137M 10.78M 10.54M 453M EV / Sales 2024
0.81x
EV / Sales 2025 0.67x
Free-Float
-
Yield 2024
1.39%
Yield 2025 1.63%
06-19 Sandu Pharmaceuticals Limited Announces Demise of Umesh Sandu, Member of Audit Committee and Stakeholders Relationship Committee CI
06-19 Sandu Pharmaceuticals Limited Announces the Demise of Umesh Sandu, Managing Director CI
05-05 Sandu Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
05-05 Sandu Pharmaceuticals Limited Recommends Final Dividend for the Financial Year Ended 31 March 2026 CI
02-06 Sandu Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
11-12 Sandu Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025 CI
30/09/25 Sandu Pharmaceuticals Limited Approves the Continuation of Shri Vijay Kajarakar as Chief Financial Officer CI
13/08/25 Sandu Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 CI
29/05/25 Sandu Pharmaceuticals Posts INR3.3 Million Profit in Fiscal Q4 MT
28/05/25 Sandu Pharmaceuticals Limited Recommends Final Dividend for the Financial Year Ended March 31, 2025, on or Before October 25, 2025 CI
28/05/25 Sandu Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2025 CI
13/02/25 Sandu Pharmaceuticals Limited Announces Resignation of Shubhada Sandu as Non Executive Non Independent Director CI
13/02/25 Sandu Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024 CI
1 day+2.94%
1 week+1.46%
Current month+1.46%
1 month-2.58%
3 months-1.05%
6 months+17.12%
Current year+5.82%
1 week 38.11
Extreme 38.11
41
1 month 37.3
Extreme 37.3
41.6
Current year 30
Extreme 30
50
1 year 30
Extreme 30
58.28
3 years 30
Extreme 30
85
5 years 30
Extreme 30
86
10 years 10.45
Extreme 10.45
86
Manager TitleAgeSince
Chief Executive Officer 58 11/07/2026
Director of Finance/CFO - 30/03/2024
Compliance Officer - -
Director TitleAgeSince
Director/Board Member 62 01/06/2011
Chairman 58 30/03/2024
Director/Board Member 69 14/08/2023
Change 5-day change 1-year change 3-year change Capi.($)
+2.94%+1.46%-17.17%-26.89% 3.9M
+0.14%-3.97%-9.10%-5.46% 13.4B
-0.84%-2.23%+4.15%+2.04% 5.09B
+0.85%-4.86%-31.42%-54.83% 5.04B
+4.49%+0.59%+6.05%-28.64% 4.02B
-4.39%-3.50%-2.52%+6.50% 3.7B
+0.84%-2.90%-6.58%-4.05% 3.66B
+1.48%-2.48%-2.84%+21.30% 3.43B
+3.37%+1.21%-11.54%-19.73% 2.41B
+0.23%-3.30%-3.43%+51.71% 1.85B
Average +0.91%-2.18%-7.44%-5.81% 4.26B
Weighted average by Cap. +0.48%-2.40%-7.33%-7.61%

Financials

2024 2025
Net sales 673M 7.07M 6.12M 5.71M 5.24M 9.85M 10.01M 67M 26.3M 337M 26.55M 25.97M 1.11B 672M 7.06M 6.11M 5.7M 5.23M 9.84M 10M 66.91M 26.26M 337M 26.51M 25.93M 1.11B
Net income 14.61M 154K 133K 124K 114K 214K 217K 1.46M 571K 7.32M 577K 564K 24.21M 15.52M 163K 141K 132K 121K 227K 231K 1.55M 606K 7.78M 612K 599K 25.71M
Net Debt -11.43M -120K -104K -97.01K -89K -167K -170K -1.14M -447K -5.73M -451K -441K -18.94M -21.76M -229K -198K -185K -169K -319K -324K -2.17M -850K -10.9M -858K -840K -36.05M
Logo Sandu Pharmaceuticals Limited
Sandu Pharmaceuticals Limited is an India-based company, which is mainly engaged in the business of manufacturing and trading of ayurvedic medicines under the brand name, SANDU. The Company's product category includes digestive health, immunity, muscle and bone health, respiratory health, wellness, and others. Its digestive health products focus on constipation, hyperacidity, indigestion and flatulence, and loose motions, among others. Its wellness products cover female wellness, male wellness and mother and child. Its respiratory health products focus on respiratory health, asthma, and cold and cough. Its ayurveda category includes herbs, panchakarma, dincharya, rutucharya, ahar vihar, arogyadarshika, prakruti and yoga. The Company also offers products, such as an immunity kit and a power herbs range. Its products are manufactured using in-house know-how supplied by Sandu Brothers Private Limited. The Company's products are sold through e-commerce marketplaces.
Employees
303
Date Price Change Volume
07/08/26 ₹39.61 +2.94% 1,140
06/08/26 ₹38.48 -3.32% 2,251
05/08/26 ₹39.80 +1.45% 3,738
04/08/26 ₹39.23 -3.59% 836
03/08/26 ₹40.69 +4.23% 172
  1. Stock Market
  2. Stocks
  3. 524703 Stock